Biobanking, In-Vitro and Protein - Clinical Research Informer

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Biobanking

In-Vitro

Protein

Alnylam identifies gene to lower abdominal fat and decrease cardiovascular risk

Pharmaceutical Technology

AUGUST 11, 2022

Using data from the UK Biobank database, genomic sequencing data for 360,000 individuals were obtained and the findings were confirmed in animal models that demonstrated a higher expression of the INHBE gene in obese monkeys when compared to more lean monkeys.

Gene

Gene Biobanking Gene Expression In-Vitro

Reflecting on ELRIG’s Drug Discovery 2022

Drug Discovery World

OCTOBER 13, 2022

Over the two days at ExCel, 1554 delegates attended the event. Of those delegates, 75% work in drug discovery. There were 127 exhibitors, 180 posters, 40 technology speakers, 52 scientific speakers as well as a series of eight seminars focused on automation and technology which DDW organised and moderated in the dedicated Tech Theatre. .

Drugs

Drugs In-Vivo In-Vitro Biobanking

Alnylam identifies gene to lower abdominal fat and decrease cardiovascular risk

Reflecting on ELRIG’s Drug Discovery 2022

Stay Connected